Ref. 65-2023 Postdoctoral Fellow | Somm Excellence Alliance
Welcome to the Latest Job Vacancies Site 2023 and at this time we would like to inform you of the Latest Job Vacancies from the Somm Excellence Alliance with the position of Ref. 65-2023 Postdoctoral Fellow | Somm Excellence Alliance which was opened this.
If this job matches your qualifications, please send your application directly through our latest Job site. Indeed, every job is not easy to apply because it must meet several qualifications and requirements that we must meet in accordance with the standard criteria of the Company who are looking for potential candidates to work. Good job information Ref. 65-2023 Postdoctoral Fellow | Somm Excellence Alliance below matches your qualifications. Good Luck: D
The fellow will have the opportunity to work with many high-throughput techniques to study transcriptional, epigenetic, and metabolic dysregulations found in GI cancer patients (e.g., RNA-seq, ChIP-seq, ATAC-seq, MeDIP-seq, metabolomics) as well as the use of patient-derived preclinical models to perform drug screens ex vivo and in vivo. This privileged environment affords VHIO direct access to...
The Vall d´Hebron Institute of Oncology (VHIO) Seeks a “Postdoctoral Fellow” Reference: Ref. 65-2023 Application deadline: 30/11/2023 Number of vacancies: 1 The Vall d´Hebron Institute of Oncology´s (VHIO) Upper Gastrointestinal Cancer Translational Research Group headed by Dr. Teresa Macarulla MD PhD is recruiting a postdoctoral fellow. Group description: The Upper Gastrointestinal (GI) Cancer Translational Research Group at the prestigious Vall d’Hebron Institute of Oncology (VHIO) is a dynamic and innovative team of clinical and translational researchers. Our group is dedicated to advancing pancreaticobiliary cancer research from bench to bede, focusing on three key areas. First and foremost, we are dedicated to unraveling prognostic and predictive factors related to targeted and immune therapies. We are interested inentifying potential biomarkers based on transcriptional, epigic, and metabolic features. Our goal is to unearth biomarkers that can effectively forecast patient responses to these treatments, thus enabling us to offer personalized therapeutic options that enhance overall patient oues. Additionally, we are actively engaged in creating patient-derived models that hold significant relevance for preclinical investigations. These models serve as invaluable tools for advancing our understanding of upper GI cancers and evaluating potential treatment strategies. Furthermore, we aremitted to conducting rigorous preclinical and clinical assessments of novel therapeutic approaches. Our particular emphasis lies in developing molecular therapies designed to target the aberrant signaling pathways associated with pancreatic and bile duct cancers. In this regard, our group has made pioneering contributions, leading early-phase clinical trials and spearheading translational studies to fortify anti-cancer strategies for upper GI malignancies. Here are several examples of our work: Elife 12, doi:10.7554/eLife.83951 (2023). Clin Cancer Res 29, 432-445, (2023). Clin Cancer Res 28, 1662-1671, (2022). Eur J Cancer 171, 232-241, (2022). Eur J Cancer 175, 299-310, (2022). J Clin Oncol 40, 3929-3939, (2022). JAMA Oncol 7, 1669-1677, (2021). Lancet Gastroenterol Hepatol 6, 803-815, (2021). J Clin Oncol 39, 1108-1118, (2021). Nat Med 26, 878-885, (2020). Nat G 52, 655-661, (2020). Lancet Oncol 21, 796-807, (2020). Nat Cell Biol 21, 824-834, (2019). J Clin Oncol 37, 230-238, (2019). N Engl J Med 381, 317-327, (2019). Cell Stem Cell 23, 727-741 e729, (2018). Job description: We seek an enthusiastic postdoctoral fellow willing to participate in our translational project supported by the European Transcan-3 program. This project is at the interface of clinical and preclinical studies. The fellow will have the opportunity to work with many high-throughput techniques to study transcriptional, epigic, and metabolic dysregulations found in GI cancer patients (e.g., RNA-seq, ChIP-seq, ATAC-seq, MeDIP-seq, metabolomics) as well as the use of patient-derived preclinical models to perform drug screens ex vivo and in vivo. Moreover, we encourage the fellow to acquire bioinformaticspetence for genome-e data analysis. The fellow will work within an international consortium of groups from Spain, Germany, and Israel. Requirements:
- This offer is open to canates of any nationality.
- Canates must have obtained a PhD (biomedical-related areas) or MD.
- Canates who expect to be awarded a PhD or MD degree by December 2023 are eligible to apply.
- Canates must have an excellent academic record and be the principal author of at least one peer-reviewed publication.
- Canates must have a high working knowledge of English.
- To be successful in this application, the canate will be a very organized, motivated, team-oriented indiual.
- Salary will be negotiated according to the institutional gelines.
- Start date: December 1st 2023
Deadline: November 30, 2023 Job category: Postdoc Area: Life Sciences
- Company Name : Somm Excellence Alliance
- Open Position : Ref. 65-2023 Postdoctoral Fellow | Somm Excellence Alliance
- Location Job : Barcelona, Barcelona provincia
- Country Job : ES
How to Submit an Application:
After reading and knowing the criteria and minimum requirements for qualifications that have been explained from the Ref. 65-2023 Postdoctoral Fellow | Somm Excellence Alliance job info - Somm Excellence Alliance Barcelona, Barcelona provincia above, thus jobseekers who feel they have not met the requirements including education, age, etc. and really feel interested in the latest job vacancies Ref. 65-2023 Postdoctoral Fellow | Somm Excellence Alliance job info - Somm Excellence Alliance Barcelona, Barcelona provincia in 17-09-2023 above, should as soon as possible complete and compile a job application file such as a job application letter, CV or curriculum vitae, FC diploma and transcripts and other supplements as described above, in order to register and take part in the admission selection for new employees in the company referred to, sent via the Next Page link below.